![PAH](https://www.adcreviews.com/wp-content/uploads/2022/10/PAH-211x160.jpg)
Merck’s Pulmonary Arterial Hypertension Drug Sotatercept Phase III Clinical Success
Merck announced that the Phase III STELLAR clinical study of sotatercept in pulmonary arterial hypertension (PAH) achieved positive top-line results, meeting the primary endpoint and